A composition with the function of activating hsf‑1 transcription and its use
A technology of HSF-1 and composition, which can be applied to medical preparations containing active ingredients, drug combinations, organic active ingredients, etc., and can solve the problems such as cell senescence and death that have not been seen
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0025] Embodiment 1: An embodiment of the composition of the present invention having the function of activating HSF-1 transcription
[0026] The composition is a mixture of resveratrol, β-hydroxymethyl butyrate, 3,4-dichloroisocoumarin and polyinosinic acid cytosine nucleotides, and the dosage of the resveratrol is 0.035 parts by weight, the consumption of the β-hydroxymethyl butyrate is 0.200 parts by weight, the consumption of 3,4-dichloroisocoumarin is 0.010 parts by weight, and the consumption of polyinosinic acid cytosine nucleotides is 0.020 parts by weight. The composition can be obtained by mixing the above materials according to the above weight parts, and the composition here is called composition A.
Embodiment 2
[0027] Embodiment 2: An embodiment of the composition with the function of activating HSF-1 transcription according to the present invention
[0028] The composition is a mixture of resveratrol, β-hydroxymethyl butyrate, 3,4-dichloroisocoumarin and polyinosinic acid cytosine nucleotides, and the dosage of the resveratrol is 0.500 parts by weight, the consumption of the β-hydroxymethyl butyrate is 3.000 parts by weight, the consumption of 3,4-dichloroisocoumarin is 0.200 parts by weight, and the consumption of polyinosinic acid cytosine nucleotides is 0.050 parts by weight. The composition can be obtained by mixing the above materials according to the above weight parts, and the composition here is called composition A.
Embodiment 3
[0029] Embodiment 3: An embodiment of the composition having the function of activating HSF-1 transcription according to the present invention
[0030] The composition is a mixture of resveratrol, β-hydroxymethyl butyrate, 3,4-dichloroisocoumarin and polyinosinic acid cytosine nucleotides, and the dosage of the resveratrol is 0.20 parts by weight, the consumption of the β-hydroxymethyl butyrate is 1.00 parts by weight, the consumption of 3,4-dichloroisocoumarin is 0.10 parts by weight, and the consumption of polyinosinic acid cytosine nucleotides is 0.03 parts by weight. The composition can be obtained by mixing the above materials according to the above weight parts, and the composition here is called composition A.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com